Dysregulation of the type I interferon system in adult‐onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease
Authors:
- 27 September 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 167 (6) , 1236-1244
Abstract
Background It has been speculated that viral infection might be one of the potential aetiologies for adult‐onset clinically amyopathic dermatomyositis (CADM). The molecular pathogenesis remains largely unknown. Objectives To explore whether dysregulation of the type I interferon (IFN) system is involved in the pathogenesis of CADM. Methods We studied 16 patients with CADM and compared them with healthy control subjects (n = 20) and patients with classic dermatomyositis (DM, n = 16) and polymyositis (PM, n = 16). Expressions of mRNA for serial toll‐like receptor genes (TLR2, TLR3, TLR4, TLR7, TLR8 and TLR9) and type I IFN‐regulated genes (IRF7, ISG15 and MxA) in peripheral blood leucocytes (PBL) were detected by real‐time polymerase chain reaction analysis. The level of IFN‐α in blood was tested by enzyme‐linked immunosorbent assay. Results The mRNA expressions of TLR7, TLR9 and IRF7 were greatly elevated in the PBL from patients with CADM compared with controls. Upregulation of the ISG15 and MxA genes was detected in the PBL from patients with CADM, as well as from patients with classic DM. Among the four study groups, the overproduction of IFN‐α in blood was most significant in the CADM group. Especially, IFN‐α level was obviously high in the clinical interstitial lung disease (ILD) subgroup of patients with CADM. Positive correlations were found between IFN‐α concentration and other unfavourable prognostic factors of CADM‐associated ILD. Conclusions Our data suggest that the dysregulation of the type I IFN system may be implicated in CADM pathogenesis. IFN‐α may be a useful biomarker for assessing the disease severity of CADM‐associated ILD.Keywords
This publication has 33 references indexed in Scilit:
- The type I interferon system in the development of lupusSeminars in Immunology, 2011
- The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibodyRheumatology, 2009
- Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic DermatomyositisChest, 2009
- RNA helicase encoded by melanoma differentiation–associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung diseaseArthritis & Rheumatism, 2009
- Association of distinct clinical subsets with myositis‐specific autoantibodies towards anti‐155/140‐kDa polypeptides, anti‐140‐kDa polypeptides, and anti‐aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single‐centre, cross‐sectional studyScandinavian Journal of Rheumatology, 2009
- Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort studyClinical Rheumatology, 2007
- Interferon signalling network in innate defenceCellular Microbiology, 2006
- Differential roles of MDA5 and RIG-I helicases in the recognition of RNA virusesNature, 2006
- A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): A missing link within the spectrum of the idiopathic inflammatory myopathiesJournal of the American Academy of Dermatology, 2006
- Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositisArthritis & Rheumatism, 2005